Literature DB >> 15802986

The decline of incident cases of HIV-associated neurological disorders in San Francisco, 1991-2003.

James W Dilley, Sandra Schwarcz, Lisa Loeb, Ling Hsu, Kimberly Nelson, Susan Scheer.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15802986     DOI： 10.1097/01.aids.0000163944.39306.7c

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

1.  Antiretroviral neurotoxicity.

Authors:  Kevin Robertson; Jeff Liner; Rick B Meeker
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

2.  A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals.

Authors:  Ignacio Pérez-Valero; Alicia González-Baeza; Miriam Estébanez; Susana Monge; María L Montes-Ramírez; Carmen Bayón; Federico Pulido; José I Bernardino; Francisco X Zamora; Juan J González-García; María Lagarde; Asunción Hernando; Francisco Arnalich; José R Arribas
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

3.  Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity.

Authors:  Stella E Panos; Charles H Hinkin; Elyse J Singer; April D Thames; Sapna M Patel; Janet S Sinsheimer; A C Del Re; Benjamin B Gelman; Susan Morgello; David J Moore; Andrew J Levine
Journal:  Neurobehav HIV Med       Date:  2013-06-19

Review 4.  Effects of antiretroviral therapy on cognitive impairment.

Authors:  Kevin J Liner; Colin D Hall; Kevin R Robertson
Journal:  Curr HIV/AIDS Rep       Date:  2008-05       Impact factor: 5.071

Review 5.  The far-reaching HAND of cART: cART effects on astrocytes.

Authors:  Hemil Gonzalez; Anthony Podany; Lena Al-Harthi; Jennillee Wallace
Journal:  J Neuroimmune Pharmacol       Date:  2020-03-09       Impact factor: 7.285

Review 6.  LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY.

Authors:  Jose E Vidal; David R Boulware
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-09       Impact factor: 1.846

Review 7.  Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America.

Authors:  Jose E Vidal; Augusto C Penalva de Oliveira; Rafi F Dauar; David R Boulware
Journal:  Braz J Infect Dis       Date:  2013-05-10       Impact factor: 1.949

8.  Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.

Authors:  Ignacio Pérez-Valero; Ronald Ellis; Robert Heaton; Reena Deutsch; Donald Franklin; David B Clifford; Ann Collier; Benjamin Gelman; Christina Marra; John Allen McCutchan; Allison Navis; Ned Sacktor; David Simpson; Igor Grant; Scott Letendre
Journal:  AIDS       Date:  2019-03-01       Impact factor: 4.632

Review 9.  Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

Authors:  Andrea Low; Georgios Gavriilidis; Natasha Larke; Marie-Renee B-Lajoie; Olivier Drouin; John Stover; Lulu Muhe; Philippa Easterbrook
Journal:  Clin Infect Dis       Date:  2016-03-06       Impact factor: 9.079
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.